NEW YORK – Thermo Fisher Scientific said on Monday that its transplant diagnostic business has teamed up with laboratories at Emory University, Stanford University, the University of Cincinnati, and the University Health Network in Toronto to develop a COVID-19 antibody assay for transplant donors and recipients.